Arrhythmia/EP
Dabigatran "real-life" results suggest caution needed
4 COMMENT S - May 15, 2013 17:15 EDT
New data from real-life experience of dabigatran for stroke prevention in AF shows that it is often used outside prescribing recommendations, and the risk of both thromboembolism and bleeding may be raised in patients switched from warfarin.

Copenhagen, Denmark - New data from the real-life experience of dabigatran (Pradaxa, Boehringer Ingelheim) used for the prevention of stroke in atrial fibrillation (AF) patients in Denmark after the drug was first introduced shows that it was often being used outside prescribing recommendations and that the risk of both thromboembolism and bleeding may be raised in patients being switched to dabigatran from warfarin [1].

The study, published in BMJ Open on May 4, 2013, was conducted by a team led by Dr Rikke Sørensen (Copenhagen University Hospital Gentofte, Denmark).
Read full article »

Clinical cardiology
Massachusetts health reform didn't increase hospital costs, study finds
May 24, 2013 15:00 EDT

Imaging
RIPCORD: FFR during diagnostic angio may radically alter treatment plans
May 23, 2013 12:15 EDT

Clinical cardiology
Regional density of cardiologists affects MI and HF mortality risk
May 22, 2013 16:30 EDT

Interventional/Surgery
Girl trouble: Rising tide of STEMI in young women "clearly not acceptable"
May 22, 2013 08:10 EDT

Hypertension
EMA reviewing safety of dual RAS blockade for hypertension, HF
May 20, 2013 16:00 EDT

Clinical cardiology
Inhaled long-acting bronchodilators in COPD flagged again for CV hazard
May 20, 2013 16:00 EDT

Editorial programs
Debate and dialogue between top cardiovascular specialists, produced by
theheart.org's editorial team
View all »
Healthcare reform and cardiology: An even-keeled update
Healthcare reform and cardiology: An even-keeled update
May 2, 2013 08:45 EDT
Breaking embargo: PREVAIL and how we publish data from clinical trials
Breaking embargo: PREVAIL and how we publish data from clinical trials
Apr 12, 2013 16:33 EDT
ACC 2013 research highlights: A slideshow presentation
ACC 2013 research highlights: A slideshow presentation
4 COMMENTS - Mar 19, 2013 10:00 EDT
View all »Collections
heartwire collections groups our most compelling cardiology news coverage and editorial content by popular themes. Find everything on a single topic, in one place, with one click.
Erectile dysfunction and CHD
Years ago, Viagra made the unexpected transition from hypertension and angina drug...
Sodium reduction and blood pressure
Around the globe, public policy-makers, restaurateurs, and food manufacturers are...
The Myxo ring mix-up
In 2008, a heartwire investigation reported on a mitral annuloplasty ring, invented by...
Drugs, money, and glory: Is cancer beating cardiovascular disease?
Heart disease still tops the charts as the number-one killer in most developed...
Clopidogrel and PPIs
Proton-pump inhibitors have been prescribed to reduce the gastrointestinal risks of...
Close the Gap in Cardiovascular Disparities
Close the Gap – a new educational initiative designed to address disparities in cardiovascular care for the underserved populations of women, Hispanic/Latino Americans, and black Americans.
The Heart of a Woman
Resource Center (view all)

What's New